The affected batches were distributed from October 2018 to December 2020. 

The family says it is now seeking legal action over the error. 

The portable sensor, developed by specialists at the University of Notre Dame and University of Florida, targets the patient's microRNA.

The Class I recall includes units distributed from September 2020 to August 2021.

The study initially gained a lot of attention online for its findings related to myocarditis—but the authors had made a major error with their calculations. 

Starting a daily aspirin regimen in people age 60 or older can cause potentially serious harm including internal bleeding, the USPSTF warned Tuesday.

The jury's decision is being appealed, according to an attorney involved in the case. 

The group urged all eligible individuals to get vaccinated, noting that vaccine-related side effects have been quite rare. 

Patients given clopidogrel plus aspirin faced a lower risk of adverse events than those given ticagrelor plus aspirin.

According to a new analysis, the widespread use of remote heart failure care during the pandemic may lead to increased telemedicine use in the future.